Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia

BACKGROUND: Minimal residual disease (MRD) monitoring is an important tool to optimally address post-transplant management of acute myeloid leukemia (AML) patients. METHODS: We retrospectively analyzed the impact of bone marrow CD34+ molecular chimerism and WT1 on the outcome of a consecutive series...

Descripción completa

Detalles Bibliográficos
Autores principales: Malagola, Michele, Polverelli, Nicola, Beghin, Alessandra, Bolda, Federica, Comini, Marta, Farina, Mirko, Morello, Enrico, Radici, Vera, Accorsi Buttini, Eugenia, Bernardi, Simona, Re, Federica, Leoni, Alessandro, Bonometti, Davide, Brugnoni, Duilio, Lanfranchi, Arnalda, Russo, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025489/
https://www.ncbi.nlm.nih.gov/pubmed/36950550
http://dx.doi.org/10.3389/fonc.2023.1133418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025489/
https://www.ncbi.nlm.nih.gov/pubmed/36950550
http://dx.doi.org/10.3389/fonc.2023.1133418

Ejemplares similares